A detailed history of Sante Capital Fund, LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Sante Capital Fund, LP holds 10,153 shares of ABBV stock, worth $1.8 Million. This represents 2.79% of its overall portfolio holdings.

Number of Shares
10,153
Holding current value
$1.8 Million
% of portfolio
2.79%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $1.36 Million - $1.56 Million
10,153 New
10,153 $1.36 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sante Capital Fund, LP Portfolio

Follow Sante Capital Fund, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sante Capital Fund, LP, based on Form 13F filings with the SEC.

News

Stay updated on Sante Capital Fund, LP with notifications on news.